Global Post-Traumatic Stress Disorder Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 93 pages | ID: G7A346C01C21EN
LP Information

Abstracts

According to this study, the global Post-Traumatic Stress Disorder Therapeutics market size will reach US$ 3305 million by 2031.

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Post-Traumatic Stress Disorder Therapeutics Industry Forecast” looks at past sales and reviews total world Post-Traumatic Stress Disorder Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Post-Traumatic Stress Disorder Therapeutics sales for 2025 through 2031. With Post-Traumatic Stress Disorder Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post-Traumatic Stress Disorder Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Post-Traumatic Stress Disorder Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post-Traumatic Stress Disorder Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post-Traumatic Stress Disorder Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post-Traumatic Stress Disorder Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post-Traumatic Stress Disorder Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Post-Traumatic Stress Disorder Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antidepressants
• Anti-Anxiety Drugs
• Others

Segmentation by Application:

• Hospitals
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer, Inc.
• GlaxoSmithKline plc
• Otsuka Pharmaceutical Co., Ltd
• Novartis AG
• AstraZeneca Plc
• Azevan Pharmaceuticals, Inc.
• Bionomics Ltd.
• Tonix Pharmaceuticals Holding Corp.
• Apotex, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size (2020-2031)
  2.1.2 Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Post-Traumatic Stress Disorder Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Post-Traumatic Stress Disorder Therapeutics Segment by Type
  2.2.1 Antidepressants
  2.2.2 Anti-Anxiety Drugs
  2.2.3 Others
2.3 Post-Traumatic Stress Disorder Therapeutics Market Size by Type
  2.3.1 Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Post-Traumatic Stress Disorder Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinic
  2.4.3 Others
2.5 Post-Traumatic Stress Disorder Therapeutics Market Size by Application
  2.5.1 Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)

3 POST-TRAUMATIC STRESS DISORDER THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Player
  3.1.1 Global Post-Traumatic Stress Disorder Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 POST-TRAUMATIC STRESS DISORDER THERAPEUTICS BY REGION

4.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2020-2025)
4.2 Global Post-Traumatic Stress Disorder Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Post-Traumatic Stress Disorder Therapeutics Market Size Growth (2020-2025)
4.4 APAC Post-Traumatic Stress Disorder Therapeutics Market Size Growth (2020-2025)
4.5 Europe Post-Traumatic Stress Disorder Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2020-2025)
5.2 Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025)
5.3 Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2020-2025)
6.2 APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025)
6.3 APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2020-2025)
7.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025)
7.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL POST-TRAUMATIC STRESS DISORDER THERAPEUTICS MARKET FORECAST

10.1 Global Post-Traumatic Stress Disorder Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Post-Traumatic Stress Disorder Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Post-Traumatic Stress Disorder Therapeutics Forecast
  10.1.3 APAC Post-Traumatic Stress Disorder Therapeutics Forecast
  10.1.4 Europe Post-Traumatic Stress Disorder Therapeutics Forecast
  10.1.5 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Forecast
10.2 Americas Post-Traumatic Stress Disorder Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.2.2 Canada Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.2.3 Mexico Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.2.4 Brazil Market Post-Traumatic Stress Disorder Therapeutics Forecast
10.3 APAC Post-Traumatic Stress Disorder Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Post-Traumatic Stress Disorder Therapeutics Market Forecast
  10.3.2 Japan Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.3.3 Korea Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.3.4 Southeast Asia Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.3.5 India Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.3.6 Australia Market Post-Traumatic Stress Disorder Therapeutics Forecast
10.4 Europe Post-Traumatic Stress Disorder Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.4.2 France Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.4.3 UK Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.4.4 Italy Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.4.5 Russia Market Post-Traumatic Stress Disorder Therapeutics Forecast
10.5 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.5.2 South Africa Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.5.3 Israel Market Post-Traumatic Stress Disorder Therapeutics Forecast
  10.5.4 Turkey Market Post-Traumatic Stress Disorder Therapeutics Forecast
10.6 Global Post-Traumatic Stress Disorder Therapeutics Forecast by Type (2026-2031)
10.7 Global Post-Traumatic Stress Disorder Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Post-Traumatic Stress Disorder Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer, Inc.
  11.1.1 Pfizer, Inc. Company Information
  11.1.2 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer, Inc. Main Business Overview
  11.1.5 Pfizer, Inc. Latest Developments
11.2 GlaxoSmithKline plc
  11.2.1 GlaxoSmithKline plc Company Information
  11.2.2 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline plc Main Business Overview
  11.2.5 GlaxoSmithKline plc Latest Developments
11.3 Otsuka Pharmaceutical Co., Ltd
  11.3.1 Otsuka Pharmaceutical Co., Ltd Company Information
  11.3.2 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Otsuka Pharmaceutical Co., Ltd Main Business Overview
  11.3.5 Otsuka Pharmaceutical Co., Ltd Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.4.3 Novartis AG Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 AstraZeneca Plc
  11.5.1 AstraZeneca Plc Company Information
  11.5.2 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 AstraZeneca Plc Main Business Overview
  11.5.5 AstraZeneca Plc Latest Developments
11.6 Azevan Pharmaceuticals, Inc.
  11.6.1 Azevan Pharmaceuticals, Inc. Company Information
  11.6.2 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Azevan Pharmaceuticals, Inc. Main Business Overview
  11.6.5 Azevan Pharmaceuticals, Inc. Latest Developments
11.7 Bionomics Ltd.
  11.7.1 Bionomics Ltd. Company Information
  11.7.2 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Bionomics Ltd. Main Business Overview
  11.7.5 Bionomics Ltd. Latest Developments
11.8 Tonix Pharmaceuticals Holding Corp.
  11.8.1 Tonix Pharmaceuticals Holding Corp. Company Information
  11.8.2 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Tonix Pharmaceuticals Holding Corp. Main Business Overview
  11.8.5 Tonix Pharmaceuticals Holding Corp. Latest Developments
11.9 Apotex, Inc.
  11.9.1 Apotex, Inc. Company Information
  11.9.2 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
  11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Apotex, Inc. Main Business Overview
  11.9.5 Apotex, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Post-Traumatic Stress Disorder Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Anti-Anxiety Drugs
Table 5. Major Players of Others
Table 6. Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Post-Traumatic Stress Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Products Offered
Table 15. Post-Traumatic Stress Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Post-Traumatic Stress Disorder Therapeutics
Table 40. Key Market Challenges & Risks of Post-Traumatic Stress Disorder Therapeutics
Table 41. Key Industry Trends of Post-Traumatic Stress Disorder Therapeutics
Table 42. Global Post-Traumatic Stress Disorder Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Post-Traumatic Stress Disorder Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Post-Traumatic Stress Disorder Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer, Inc. Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 47. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 48. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer, Inc. Main Business
Table 50. Pfizer, Inc. Latest Developments
Table 51. GlaxoSmithKline plc Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 52. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 53. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. GlaxoSmithKline plc Main Business
Table 55. GlaxoSmithKline plc Latest Developments
Table 56. Otsuka Pharmaceutical Co., Ltd Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 57. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 58. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Otsuka Pharmaceutical Co., Ltd Main Business
Table 60. Otsuka Pharmaceutical Co., Ltd Latest Developments
Table 61. Novartis AG Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 62. Novartis AG Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 63. Novartis AG Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis AG Main Business
Table 65. Novartis AG Latest Developments
Table 66. AstraZeneca Plc Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 67. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 68. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. AstraZeneca Plc Main Business
Table 70. AstraZeneca Plc Latest Developments
Table 71. Azevan Pharmaceuticals, Inc. Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 72. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 73. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Azevan Pharmaceuticals, Inc. Main Business
Table 75. Azevan Pharmaceuticals, Inc. Latest Developments
Table 76. Bionomics Ltd. Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 77. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 78. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bionomics Ltd. Main Business
Table 80. Bionomics Ltd. Latest Developments
Table 81. Tonix Pharmaceuticals Holding Corp. Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 82. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 83. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Tonix Pharmaceuticals Holding Corp. Main Business
Table 85. Tonix Pharmaceuticals Holding Corp. Latest Developments
Table 86. Apotex, Inc. Details, Company Type, Post-Traumatic Stress Disorder Therapeutics Area Served and Its Competitors
Table 87. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product Offered
Table 88. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Apotex, Inc. Main Business
Table 90. Apotex, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Post-Traumatic Stress Disorder Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Post-Traumatic Stress Disorder Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Post-Traumatic Stress Disorder Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Post-Traumatic Stress Disorder Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type in 2024
Figure 10. Post-Traumatic Stress Disorder Therapeutics in Hospitals
Figure 11. Global Post-Traumatic Stress Disorder Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Post-Traumatic Stress Disorder Therapeutics in Clinic
Figure 13. Global Post-Traumatic Stress Disorder Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Post-Traumatic Stress Disorder Therapeutics in Others
Figure 15. Global Post-Traumatic Stress Disorder Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Post-Traumatic Stress Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Post-Traumatic Stress Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Post-Traumatic Stress Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Post-Traumatic Stress Disorder Therapeutics Value Market Share by Country in 2024
Figure 24. United States Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Post-Traumatic Stress Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Post-Traumatic Stress Disorder Therapeutics Market Size 2026-2031 ($ millions)